AdiStem Ltd.

AdiStem owns proprietary technologies for stem cell administration that are shared with qualified medical practitioners through instructional courses, workshops and seminars. Due to its clinician and hospital relationships and collaborative efforts with medical institutions, AdiStem believes it is now a leading provider of autologous adipose-derived adult stem cell products and procedures.

There are now clinicians in the USA, Canada, Greece, South Africa, India, China, Saudi Arabia, Korea, Egypt, Turkey, Jordan, Philippines, Thailand, Malaysia, Mexico, Peru and Brazil who currently use some aspect of AdiStem technology in the treatment of patients and in further research on diseases.

Contact Information

AdiStem Ltd. is now entering into collaborative agreements with medical institutions and companies in particular countries to provide autologous stem cell transplant procedure "know-how" and to supply AdiLight-1 and AdiLight-1 Kits which are essential to "activating" stem cells derived from a patient's adipose tissue.

Research and clinical trials are currently ongoing with medical biotech establishments in the USA, Canada, Greece, South Africa, India, China, Saudi Arabia, Korea, Egypt, Turkey, Jordan, Philippines, Thailand, Malaysia, Mexico, Peru and Brazil.

For more information or inquiries, please contact:
info@AdiStem.com

or complete the following Request Form so we can contact you:

Corporate Headquarters

Regional Offices